Biosimilar infliximab use in paediatric IBD

BACKGROUND: Biosimilar infliximab became available in the UK in 2015. Paediatric experience to date on its use is limited. We prospectively evaluated the safety and efficacy of biosimilar infliximab (Remsima) in two paediatric gastroenterology networks in patients with inflammatory bowel disease. ME...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Arch Dis Child
Main Authors: Richmond, Lisa, Curtis, Lee, Garrick, Victoria, Rogers, Pam, Wilson, Michelle, Tayler, Rachel, Henderson, Paul, Hansen, Richard, Wilson, David C, Russell, Richard K
Formáid: Artigo
Teanga:Inglês
Foilsithe: BMJ Publishing Group 2018
Ábhair:
Drug Therapy
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754881/
https://ncbi.nlm.nih.gov/pubmed/28988215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2017-313404
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla